Page last updated: 2024-11-03

procyclidine and Fatigue Syndrome, Chronic

procyclidine has been researched along with Fatigue Syndrome, Chronic in 1 studies

Procyclidine: A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.
procyclidine : A tertiary alcohol that consists of propan-1-ol substituted by a cyclohexyl and a phenyl group at position 1 and a pyrrolidin-1-yl group at position 3.

Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharpe, MC1
Johnson, BA1
McCann, J1

Other Studies

1 other study available for procyclidine and Fatigue Syndrome, Chronic

ArticleYear
Mania and recovery from chronic fatigue syndrome.
    Journal of the Royal Society of Medicine, 1991, Volume: 84, Issue:1

    Topics: Adolescent; Bipolar Disorder; Droperidol; Family; Fatigue Syndrome, Chronic; Female; Humans; Procycl

1991